Back to search

Article

The efficacy and safety of pharmacotherapy for girls with central precocious puberty or early puberty: a retrospective cohort study

2024-06-12

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose</bold>: The use of recombinant human growth hormone (rhGH) for central precocious puberty (CPP) and early puberty (EP) is off-label and lacks reliable evidence for clinical practice. This study aimed to compare the long-term efficacy and safety of gonadotrophin releasing hormone analogue (GnRHa) in combination with or without rhGH for the treatment of CPP and EP, and to ex...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bdbca5cb-a5aa-5f5c-900d-4004101fe716
DOI
10.21203/rs.3.rs-4474625/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The efficacy and safety of pharmacotherapy for girls with central precocious puberty or early puberty: a retrospective cohort studyDOI 10.21203/rs.3.rs-4474625/v1
Select a neighboring publication to make it the new centre.